Maxim Group Downgrades Kiora Pharmaceuticals to Hold
Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.
Argus Research Downgrades Southwest Airlines to Hold
Argus Research analyst John Staszak downgrades Southwest Airlines (NYSE:LUV) from Buy to Hold.
Wedbush Downgrades Home Point Capital to Neutral, Lowers Price Target to $4
Wedbush analyst Jay McCanless downgrades Home Point Capital (NASDAQ:HMPT) from Outperform to Neutral and lowers the price target from $5.5 to $4.
BMO Capital Downgrades Dollar Gen to Market Perform
BMO Capital analyst Kelly Bania downgrades Dollar Gen (NYSE:DG) from Outperform to Market Perform.
Atlantic Equities Downgrades Charter Communications to Neutral, Lowers Price Target to $477
Atlantic Equities analyst Hamilton Faber downgrades Charter Communications (NASDAQ:CHTR) from Overweight to Neutral and lowers the price target from $755 to $477.
Morgan Stanley Downgrades TaskUs to Equal-Weight, Lowers Price Target to $19
Morgan Stanley analyst James Faucette downgrades TaskUs (NASDAQ:TASK) from Overweight to Equal-Weight and lowers the price target from $28 to $19.
Raymond James Downgrades CME Group to Market Perform
Raymond James analyst Patrick O'Shaughnessy downgrades CME Group (NASDAQ:CME) from Outperform to Market Perform.
Evercore ISI Group Downgrades American Equity Inv to In-Line, Raises Price Target to $44
Evercore ISI Group analyst Thomas Gallagher downgrades American Equity Inv (NYSE:AEL) from Outperform to In-Line and raises the price target from $42 to $44.
Barclays Downgrades Revolve Gr to Underweight, Lowers Price Target to $20
Barclays analyst Ross Sandler downgrades Revolve Gr (NYSE:RVLV) from Equal-Weight to Underweight and lowers the price target from $30 to $20.
JP Morgan Downgrades Vroom to Underweight
JP Morgan analyst Rajat Gupta downgrades Vroom (NASDAQ:VRM) from Neutral to Underweight.